Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yuriko Hajika"'
Autor:
Yuji Kawaguchi, Yuriko Hajika, Maho Rinka, Koji Masumoto, Jun Sawa, Kenji Hamazaki, Yasuro Kumeda
Publikováno v:
Journal of Diabetes Investigation, Vol 15, Iss 5, Pp 598-607 (2024)
ABSTRACT Aim/Introduction Insulin glargine U100/lixisenatide and insulin degludec/liraglutide are fixed‐ratio combinations containing basal insulin and a glucagon‐like peptide‐1 receptor agonist capable of reducing both fasting and postprandial
Externí odkaz:
https://doaj.org/article/82ee400975cd4048805fbe451dafa9f3
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-10 (2023)
Abstract Background Arteriosclerosis and non-alcoholic fatty liver disease are major complications of diabetes mellitus. Hyperglycemia, insulin resistance, obesity, and metabolic syndrome are associated with the progression of these complications. So
Externí odkaz:
https://doaj.org/article/b7fd425bae104e0680d46bedf59b9aac
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-5 (2023)
Abstract Background Absolute polycythemia can be primary or secondary. Erythropoietin-producing diseases (for example, hypoxia) are the major cause of secondary polycythemia. There are reports of polycythemia secondary to hydronephrosis. However, to
Externí odkaz:
https://doaj.org/article/d0ff05606174465eadfe63af598764ff
Autor:
Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika, Narumi Ashida, Koji Masumoto, Jun Sawa, Kenji Hamazaki, Yasuro Kumeda
Publikováno v:
Journal of Diabetes Investigation, Vol 13, Iss 3, Pp 505-514 (2022)
ABSTRACT Aims/Introduction Multiple daily injection therapy for early glycemic control in patients with type 2 diabetes mellitus is associated with hypoglycemia and weight gain. This study aimed to compare the efficacy (time in range of glucose level
Externí odkaz:
https://doaj.org/article/f6c55487fbe349faba09d65d38666741
Publikováno v:
BMC Geriatrics, Vol 22, Iss 1, Pp 1-5 (2022)
Abstract Background Adaptive support ventilation (ASV) is a proposed treatment option for central sleep apnea (CSA). Although the effectiveness of ASV remains unclear, some studies have reported promising results regarding the use of ASV in patients
Externí odkaz:
https://doaj.org/article/2d0df26b982e4adfb6614686d7b88635
Autor:
Waki Imoto, Koichi Yamada, Yuriko Hajika, Kousuke Okamoto, Yuka Myodo, Makoto Niki, Gaku Kuwabara, Kazushi Yamairi, Wataru Shibata, Naoko Yoshii, Kiyotaka Nakaie, Kazutaka Yoshizawa, Hiroki Namikawa, Tetsuya Watanabe, Kazuhisa Asai, Hiroshi Moro, Yukihiro Kaneko, Tomoya Kawaguchi, Yoshiaki Itoh, Hiroshi Kakeya
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-5 (2020)
Abstract Background Good’s syndrome (GS) is characterized by immunodeficiency, and can lead to severe infection, which is the most significant complication. Although Mycobacterium rarely causes infection in patients with GS, disseminated nontubercu
Externí odkaz:
https://doaj.org/article/7b622cd8115f48eb9711b10d836747bf
Autor:
Jun Sawa, Yasuro Kumeda, Shoko Miyamoto, Koji Masumoto, Yuriko Hajika, Kenji Hamazaki, Narumi Ashida, Yuji Kawaguchi
Publikováno v:
Journal of Diabetes Investigation. 13:505-514
AIMS/INTRODUCTION Multiple daily injection therapy for early glycemic control in patients with type 2 diabetes mellitus is associated with hypoglycemia and weight gain. This study aimed to compare the efficacy (time in range of glucose level 70-180 m
Publikováno v:
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics. 59(2)
The patient was 82-year-old man with type 1 diabetes mellitus. He had been using insulin degludec (IDeg) and insulin glulisine (IGlu) for treatment. He was admitted to our hospital due to diabetic ketoacidosis. As he started eating after recovery, we
Autor:
Yuji Kawaguchi, Yuriko Hajika, Narumi Ashida, Koji Masumoto, Jun Sawa, Kenji Hamazaki, Yasuro Kumeda
Publikováno v:
Advances in Therapy. 40:381-382
Autor:
Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika, Narumi Ashida, Tomoe Hirota, Koji Masumoto, Jun Sawa, Kenji Hamazaki, Yasuro Kumeda
Publikováno v:
Advances in therapy. 39(6)
We aimed to compare the efficacy of insulin degludec/insulin aspart (IDegAsp) and insulin degludec/liraglutide (IDegLira) in controlling glucose fluctuation and suppressing postprandial glucose levels using intermittently scanned continuous glucose m